Literature DB >> 786116

Myasthenia gravis, corticosteroids, anticholinesterases.

W K Engel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 786116     DOI： 10.1111/j.1749-6632.1976.tb47720.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  5 in total

Review 1.  Induction of auto-immune syndromes by penicillamine therapy in rheumatoid arthritis and other diseases.

Authors:  I A Jaffe
Journal:  Springer Semin Immunopathol       Date:  1981

2.  The relationship of plasma levels of pyridostigmine to clinical effect in patients with myasthenia gravis.

Authors:  S C Davison; N M Hyman; A Dehghan; K Chan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-12       Impact factor: 10.154

3.  Treatment of myasthenia gravis. Report on 139 patients.

Authors:  C Scoppetta; P Tonali; A Evoli; P David; F Crucitti; M L Vaccario
Journal:  J Neurol       Date:  1979       Impact factor: 4.849

4.  The in vivo effects of corticosteroids on thymocyte subsets in myasthenia gravis.

Authors:  S Berrih; D Safar; P Levasseur; C Gaud; J F Bach
Journal:  J Clin Immunol       Date:  1984-03       Impact factor: 8.317

5.  Prolonged neuromuscular blockade with atracurium.

Authors:  M D Bizzarri-Schmid; S P Desai
Journal:  Can Anaesth Soc J       Date:  1986-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.